Rep. Walden: Bipartisan Committee Leaders Request Briefing on Reporting Requirements for Generic Drugs
March 07, 2020
March 07, 2020
WASHINGTON, March 7 -- Rep. Greg Walden, R-Oregon, ranking Republican member of the House Energy and Commerce Committee, issued the following news release:
Bipartisan Energy and Commerce Committee leaders sent a letter to the Food and Drug Administration (FDA) Commissioner Dr. Stephen M. Hahn to request a briefing on the marketing status reporting requirements of generic drugs required by the FDA Reauthorization Act of 2017 (FDARA).
Energy and Commerce Republican Leader . . .
Bipartisan Energy and Commerce Committee leaders sent a letter to the Food and Drug Administration (FDA) Commissioner Dr. Stephen M. Hahn to request a briefing on the marketing status reporting requirements of generic drugs required by the FDA Reauthorization Act of 2017 (FDARA).
Energy and Commerce Republican Leader . . .